Early detection to more accurately evaluate risk of future cardiac events, in conjunction with other clinical and diagnostic findings.6
Abbott's High Sensitive Troponin-I (hsTnI) blood test can help to identify patients who are at high-risk or potentially at high-risk of heart attacks, heart failure or cardiovascular disease, including cardiovascular death, MI, coronary revascularization, heart failure, or ischemic stroke. The result, in conjunction with clinical and diagnostic findings, can then be used to prioritize the care of at-risk patients and develop a treatment plan that mitigates the risk of unfavorable outcomes.2,3